subject area of
- Adjuvant therapy for cancer of the colon. Academic Article
- Antiemetic Effectiveness and Nausea and Vomiting Incidence During Capecitabine and Oxaliplatin Chemotherapy Academic Article
- BCL-2 family protein BOK is a positive regulator of uridine metabolism in mammals Academic Article
- Biomarkers of 5-fu response in colon cancer [Brief Commentary] Comment
- Bleb vascularity following post-trabeculectomy subconjunctival bevacizumab: A pilot study Academic Article
- Compensatory mechanisms in platelet production: The response of Sl/Sl(d) mice to 5-fluorouracil Academic Article
- Correlation of extended RAS and PIK3CA gene mutation status with outcomes from the phase III AGITG MAX STUDY involving capecitabine alone or in combination with bevacizumab plus or minus mitomycin C in advanced colorectal cancer Academic Article
- Customizing chemotherapy for colon cancer: the potential of gene expression profiling Academic Article
- Dose-intense weekly cyclophosphamide, methotrexate, 5-fluorouracil, vincristine and prednisolone (CMFP) in advanced breast cancer Academic Article
- Effect of immunosuppressive agents on hepatocyte apoptosis post-liver transplantation Academic Article
- Efficacy, Tolerability, and Biomarker Analyses of Once-Every-2-Weeks Cetuximab Plus First-Line FOLFOX or FOLFIRI in Patients With KRAS or All RAS Wild-Type Metastatic Colorectal Cancer: The Phase 2 APEC Study Academic Article
- Gene Expression Profiling-Based Prediction of Response of Colon Carcinoma Cells to 5-Fluorouracil and Camptothecin Academic Article
- Impact of KRAS and BRAF gene mutation status on outcomes from the phase III AGITG MAX trial of capecitabine alone or in combination with bevacizumab and mitomycin in advanced colorectal cancer Conference Paper
- Management of Colorectal Cancer in Elderly Patients Academic Article
- Metabolic response to preoperative chemotherapy predicts prognosis for patients undergoing surgical resection of colorectal cancer metastatic to the liver Academic Article
- Oral versus intravenous fluoropyrimidines for colorectal cancer Academic Article
- Prognostic impact and the relevance of PTEN copy number alterations in patients with advanced colorectal cancer (CRC) receiving bevacizumab* Academic Article
- Rapid Selection against Truncation Mutants in Yeast Reverse Two-Hybrid Screens Academic Article
- Survival Associated with 5-Fluorouracil–Based Adjuvant Chemotherapy among Elderly Patients with Node-Positive Colon Cancer Academic Article
- Targeted chemoradiation in metastatic colorectal cancer: A phase i trial of 131i-hua33 with concurrent capecitabine Academic Article
- Use of Adjuvant Chemotherapy and Radiation Therapy for Rectal Cancer Among the Elderly: A Population-Based Study Academic Article
- Variations in the use of adjuvant chemotherapy for node-positive colon cancer in the elderly: A population-based study Academic Article
- Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer Academic Article